Ultragenyx Share Price

Ultragenyx Share Price

NASDAQ: RARE | Small Cap | Healthcare
$16.48
-$0.72 (-4.18%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Ultragenyx Stock Performance

Open
$17.10
Prev. Close
$17.20
Circuit Range
N/A
Day Range
$16.43 - $17.34
Year Range
$12.73 - $39.38
Volume
2,57,845
Average Traded
$16.65

Ultragenyx Share Price Today

As of 22 November 2026, Ultragenyx Pharmaceutical Inc.'s share price is $16.48. The stock opened at $17.10, compared to its previous close of $17.20. During today's trading session, Ultragenyx Pharmaceutical Inc.'s share price traded between $16.43 and $17.34, with an average price of $16.89. Over the past 52 weeks, the stock has recorded a high of $39.38 and a low of $12.73. In terms of performance, Ultragenyx Pharmaceutical Inc.'s share price has declined by 31.10% over the last six months and is down 52.59% on a year-on-year basis.

Ultragenyx Share Price Chart

Line chart of the Ultragenyx price trend over the selected period. The price fell overall, ranging from 16.44 to 17.34, ending at 16.48.
$16.43$17.34
L
Show Current Price
H

Ultragenyx Stock Fundamentals & Key Indicators

Market Cap
$1.63B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-5.14
Revenue (TTM)
$673.00B
Return On Equity (TTM)
139.24%
Profit Margin
-85.44%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
8.21%

Ultragenyx Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$207.28$136.00$214.00$173.00
Net Profit-$128.56-$185.00-$92.00-$118.00
Net Profit Margin-62.02%-136.03%-42.99%-68.21%
Income ChangeN/A-43.90%50.27%-28.26%

Ultragenyx Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$363.33$434.00$560.00$673.00
Net Profit-$707.42-$607.00-$569.00-$575.00
Net Profit Margin-194.70%-139.86%-101.61%-85.44%
Income ChangeN/A14.20%6.26%-1.05%

Ultragenyx Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets581.0686.0758.83661.55
Current Assets951.0817.0732.18883.9
Total Assets1532.01503.01491.011545.44
Non Current Liabilities1221.0897.0935.16931.74
Current Liabilities384.0344.0280.44261.21
Total Liabilities1605.01241.01215.61192.95
Shareholders' Equity-80.0255.0275.41352.49

Ultragenyx Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-466.0-414.0-475.0-380.47
Investing236.0-18.0168.0-291.65
Financing478.0399.0388.0501.21

About Ultragenyx

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. The company identifies, acquires, develops, and commercializes novel products for the treatment of serious, rare, and ultra-rare diseases, with a focus on debilitating genetic conditions. Its medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients aged one year and older. Mepsevii is indicated for pediatric and adult patients for the treatment of Mucopolysaccharidosis VII. The company operates across North America, Latin America, Europe, the Middle East and Africa, and Asia-Pacific, with the majority of its revenue generated from North America.

Ultragenyx Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$16.30
$16.45
+2.21%
Oct 2026
$14.96
$16.09
+6.95%
Sep 2026
$25.37
$15.04
-42.73%
Aug 2026
$24.68
$26.27
+5.54%
Jul 2026
$33.31
$24.89
-25.47%
Jun 2026
$23.52
$33.40
+39.58%
May 2026
$24.97
$23.93
-3.08%
Apr 2026
$21.02
$24.68
+18.00%
Mar 2026
$22.52
$20.92
-10.52%
Feb 2026
$23.95
$23.38
-2.75%
Jan 2026
$22.89
$24.04
+4.50%
Dec 2025
$33.96
$23.00
-33.84%

Ultragenyx Share Price FAQs